Prof. Jinghai Wan 万经海
Chief Physician, Professor
Department of Neurosurgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive and microsurgical treatment of brain tumors, including gliomas, metastases, meningiomas, pituitary adenomas, and skull base tumors. Also performs microsurgery for spinal cord tumors.
Dr. Wan holds a medical doctorate and serves as Professor and Chief of the Department of Neurosurgery at the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences. Dr. Wan is a doctoral and postdoctoral supervisor at Peking Union Medical College and a doctoral supervisor at Anhui Medical University.
Professional roles
- Vice Chair, Neuro-Oncology Professional Committee, Chinese Society of Clinical Oncology (CSCO)
- Standing Committee Member, Glioma Professional Committee, China Anti-Cancer Association
- Deputy Leader, Brain Metastasis Group, China Anti-Cancer Association
- Member, Skull Base Surgery Professional Committee, China International Exchange and Promotive Association for Medical and Health Care
Name order: in Chinese the family name comes first (Wan Jinghai). Papers usually list the name as Jinghai Wan or Wan J.
Selected publications
52 papers on PubMed matched by name and affiliation; 28 as first or senior author since 2016. Most recent first- or senior-author papers:
- Diagnostics (Basel), 2026 (senior author): Development and Temporal Validation of a Three-Metabolite Cerebrospinal Fluid Model for the Diagnosis of Leptomeningeal Metastasis from Solid Tumors. PubMed 42938156
- J Clin Med, 2026 (senior author): The Efficacy and Safety of Adding Teniposide to Temozolomide Plus Bevacizumab in Recurrent Grade 4 Glioma: A Real-World Exploratory Single-Center Study. PubMed 42941343
- J Clin Med, 2026 (senior author): Ommaya Reservoir-Based Cerebrospinal Fluid Chemotherapy for Leptomeningeal Metastasis in the Era of Targeted Therapy: Safety, Survival, and Exploratory Prognostic Factors from a Single-Center Cohort. PubMed 42941324
- IBRO Neurosci Rep, 2026 (senior author): Lipid-associated macrophage remodeling is present in the tumor microenvironment after high-grade glioma recurrence. PubMed 41938834
- J Med Internet Res, 2024 (senior author): Combining Clinical-Radiomics Features With Machine Learning Methods for Building Models to Predict Postoperative Recurrence in Patients With Chronic Subdural Hematoma: Retrospective Cohort Study. PubMed 39197165
- Digit Health, 2023 (senior author): Construction of a predictive model based on MIV-SVR for prognosis and length of stay in patients with traumatic brain injury: Retrospective cohort study. PubMed 38053736
- Exp Ther Med, 2023 (senior author): Online dynamic nomogram for predicting pain recurrence after microvascular decompression in trigeminal neuralgia. PubMed 37602298
- Clinics (Sao Paulo), 2023 (senior author): Identification of FKBP10 prognostic value in lung adenocarcinoma patients with surgical resection of brain metastases: A retrospective single-institution cohort study. PubMed 37201304
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion